Rchr
J-GLOBAL ID:201801000851347150   Update date: Apr. 15, 2024

Hiroyuki Tanaka

Hiroyuki Tanaka
Affiliation and department:
Research field  (1): Clinical pharmacy
Research theme for competitive and other funds  (1):
  • 2020 - 2023 オープンデータを利用した日本におけるHIV治療の変遷と実態の把握
Papers (51):
  • Endo K, Tanaka H, Matsuo H, Onoda O, Iida A, Ishii T. Adverse event profile of atezolizumab, bevacizumab, carboplatin, and paclitaxel combination therapy based on JADER. Anticancer research. 2024. in press. in press. in press-in press
  • Satoh M, Sakurai H, Nakamura M, Hasegawa K, Sekine S, Kato Y, Shimura T, Tanaka H, Ishii N, Utsunomiya Y, et al. Healing effects of solubilized rebamipide prepared by co-grinding on acetic acid-induced oral stomatitis in golden Syrian hamsters treated and untreated with 5-fluorouracil. Pharmacometrics. 2024. in press. in press. in press-in press
  • Ide N, Sako K, Takigawa M, Tanaka H. Risk and time-to-onset of acute kidney injury with vancomycin plus piperacillin-tazobactam combination: Analysis using JADER. In Vivo. 2024. in press. in press. in press-in press
  • Takigawa M, Tanaka H, Kobayashi T, Katahara Y, Kinoshita M, Masuda M, Iwakiri R. Elderly woman with no autoimmune disease with aseptic meningitis caused by Ccelecoxib. Cureus. 2024. 16. 3. e55348
  • 平賀秀明, 松島達也, 高橋瑞穂, 藤枝正輝, 田中博之, 増田雅行, 石井敏浩. 東邦大学薬学部における実務実習事前学習の取り組みと薬局薬剤師との協同によるセルフメディケーションに関する新規ロールプレイ課題(葛根湯)の作成. ちば県薬誌. 2024. 70. 1. 10-13
more...
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page